These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9820801)

  • 21. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.
    Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Lee CY; Teng CM
    Thromb Haemost; 2002 Jun; 87(6):1026-33. PubMed ID: 12083482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM; Brass LF; Lavker RM; Jensen PJ
    J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desensitisation of protease-activated receptor-1 (PAR-1) in rat astrocytes: evidence for a novel mechanism for terminating Ca2+ signalling evoked by the tethered ligand.
    Ubl JJ; Sergeeva M; Reiser G
    J Physiol; 2000 Jun; 525 Pt 2(Pt 2):319-30. PubMed ID: 10835036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
    Miike S; McWilliam AS; Kita H
    J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis.
    Cunningham MA; Rondeau E; Chen X; Coughlin SR; Holdsworth SR; Tipping PG
    J Exp Med; 2000 Feb; 191(3):455-62. PubMed ID: 10662791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cleaved peptide of PAR1 is a more potent stimulant of platelet-endothelial cell adhesion than is thrombin.
    Claytor RB; Michelson AD; Li JM; Frelinger AL; Rohrer MJ; Garnette CS; Barnard MR; Krueger LA; Furman MI
    J Vasc Surg; 2003 Feb; 37(2):440-5. PubMed ID: 12563219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling.
    Wang H; Ubl JJ; Reiser G
    Glia; 2002 Jan; 37(1):53-63. PubMed ID: 11746783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries.
    Hamilton JR; Nguyen PB; Cocks TM
    Circ Res; 1998 Jun; 82(12):1306-11. PubMed ID: 9648727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas.
    Jin E; Fujiwara M; Pan X; Ghazizadeh M; Arai S; Ohaki Y; Kajiwara K; Takemura T; Kawanami O
    Cancer; 2003 Feb; 97(3):703-13. PubMed ID: 12548614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease-activated receptors and their role in IL-6 and NF-IL-6 expression in human gingival fibroblasts.
    Hou L; Ravenall S; Macey MG; Harriott P; Kapas S; Howells GL
    J Periodontal Res; 1998 May; 33(4):205-11. PubMed ID: 9689616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a new peptide agonist of the protease-activated receptor-1.
    Mao Y; Jin J; Kunapuli SP
    Biochem Pharmacol; 2008 Jan; 75(2):438-47. PubMed ID: 17950254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration.
    Smith-Swintosky VL; Cheo-Isaacs CT; D'Andrea MR; Santulli RJ; Darrow AL; Andrade-Gordon P
    J Neurochem; 1997 Nov; 69(5):1890-6. PubMed ID: 9349532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin.
    Al-Ani B; Saifeddine M; Wijesuriya SJ; Hollenberg MD
    J Pharmacol Exp Ther; 2002 Feb; 300(2):702-8. PubMed ID: 11805236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protease activated receptors 1 and 4 govern the responses of human platelets to thrombin.
    Ofosu FA
    Transfus Apher Sci; 2003 Jun; 28(3):265-8. PubMed ID: 12725953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of human airway trypsin-like protease on intracellular free Ca2+ concentration in human bronchial epithelial cells.
    Miki M; Nakamura Y; Takahashi A; Nakaya Y; Eguchi H; Masegi T; Yoneda K; Yasuoka S; Sone S
    J Med Invest; 2003 Feb; 50(1-2):95-107. PubMed ID: 12630574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin.
    McNicol A; Robson CA
    J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. YD-3, a novel inhibitor of protease-induced platelet activation.
    Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
    Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.